Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00161785
Status:
COMPLETED
Last Update Posted:
2015-05-21
First Post:
2005-09-08
Brief Title:
Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 05 ml in Adults Aged 18 - 67 Years
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2015-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess
TBE antibody persistence 2 and 3 years after the third TBE vaccination with FSME-IMMUN 05ml by means of ELISA and neutralization test NT
TBE antibody response to a booster vaccination with FSME-IMMUN 05ml by means of ELISA and NT
TBE antibody persistence 2 and 3 years after the third TBE vaccination with FSME-IMMUN 05ml by means of ELISA and neutralization test NT
TBE antibody response to a booster vaccination with FSME-IMMUN 05ml by means of ELISA and NT
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None